Choice of respiratory therapy for COVID-19 patients with acute hypoxemic respiratory failure: a retrospective case series study
Background In the treatment of acute hypoxemic respiratory failure (AHRF) due to coronavirus 2019 (COVID-19), physicians choose respiratory management ranging from low-flow oxygen therapy to more invasive methods, depending on the severity of the patient’s symptoms. Recently, the ratio of oxygen sat...
Main Authors: | Kazuki Sudo, Teiji Sawa, Kohsuke Kushimoto, Ryogo Yoshii, Kento Yuasa, Keita Inoue, Mao Kinoshita, Masaki Yamasaki, Kunihiko Kooguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-04-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/15174.pdf |
Similar Items
-
ROX index versus HACOR scale in predicting success and failure of high-flow nasal cannula in the emergency department for patients with acute hypoxemic respiratory failure: a prospective observational study
by: Nattakarn Praphruetkit, et al.
Published: (2023-01-01) -
Penggunaan Indeks Respiratory-Oxygnation dalam Menentukan Keberhasilan Terapi Oksigen High Flow Nasal Cannula pada Anak Sakit Kritis dengan Distres Napas
by: Indra Saputra, et al.
Published: (2023-02-01) -
The ROX index: “Propelled” by high-flow nasal cannula therapy during the COVID-19 pandemic into greater applicability in respiratory support
by: Lucélia Luna Melo-Diaz, et al.
Published: (2022-11-01) -
Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study
by: Ming Hu, et al.
Published: (2020-12-01) -
Prediction of high-flow nasal cannula outcomes at the early phase using the modified respiratory rate oxygenation index
by: Zhe Li, et al.
Published: (2022-06-01)